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Introduction
The functional relationship between the three members of the human melatonin receptor sub-family, MT 1 and MT 2 and the orphan GPR50, also called melatonin-related receptor, is not well understood (Jockers et al., 2016) . Whereas MT 1 and MT 2 receptors bind melatonin with sub-nanomolar affinity and are the target of several clinically approved drugs (Liu et al., 2016) , GPR50 does not bind melatonin despite its 50% sequence identity with MT 1 and MT 2 receptors. Intriguingly, GPR50 is only found in mammals, and synteny analysis indicates that GPR50 is the mammalian orthologue of Mel1c, a melatonin binding receptor found in lower vertebrates (Dufourny et al., 2008) . This prompted Dufourny et al. to postulate that GPR50 lost its capacity to bind to melatonin during evolution, but the molecular basis for this remains unknown. Despite this loss-of-function phenotype, GPR50 is evolutionarily conserved and sequence variants have been associated with mental disorders (Thomson et al., 2005) and altered lipid metabolism in humans (Bhattacharyya et al., 2006) . In addition, GPR50 seems to have evolved towards a regulatory function, as GPR50 inhibits MT 1 receptor function through heteromerization and disruption of MT 1 receptor signalling by the large C-terminal region of GPR50 (Levoye et al., 2006) . The physiological importance of GPR50 is further demonstrated by the metabolic phenotype of GPR50 À/À mice (Ivanova et al., 2008; Bechtold et al., 2012) . At a structural level, previous investigations had shown that chimeric receptors in which I2-TM4-E2 or I3-TM6 regions of MT 1 receptors were replaced by the equivalent GPR50 sequences abolished 2-[ (Conway et al., 2000) . Within TM6 of the MT 1 receptor, Gly258 was identified as a critical residue, because replacement by Thr, the corresponding residue in GPR50, severely affected high-affinity 2-[ 125 I]MLT binding and cAMP signalling (Conway et al., 2000; Gubitz and Reppert, 2000) . However, these initial studies did not consider the potential participation of the flanking loops introduced into the GPR50[I2-TM4-E2-I3-TM6-MT 1 ] chimera in the restoration of melatonin function in GPR50. Based on recent crystal structures, the second extracellular (E2) loop is of particular interest as this loop has been shown to be of functional importance for class A GPCRs (Woolley and Conner, 2016) . The E2 loop was found to control access of ligands towards the orthosteric binding site [δ- (Granier et al., 2012 ), κ-(Wu et al., 2012 , μ- (Manglik et al., 2012) opioid and CXCR4 (Wu et al., 2010) , CCR5 (Tan et al., 2013) chemokine receptors], be part of the orthosteric binding site [H 1 histamine (Shimamura et al., 2011) and ET B endothelin (Shihoya et al., 2016) receptors], be the determinant of subtype selectivity [5-HT 1B (Wang et al., 2013) , 5-HT 2B (Wacker et al., 2017) , 5-HT 2C (Renault et al., 2010) and A 1 /A 2A adenosine (Glukhova et al., 2017) receptors] and be the main part of an allosteric binding site in the A 1A adenosine (Glukhova et al., 2017) and M 2 muscarinic receptors (Kruse et al., 2013) . From a functional point of view, the E2 loop was shown to be related to the biased agonism of some ligands through cAMP, ERK1/2 or Ca 2+ signalling pathways (β 1 adrenoceptors (Shukla et al., 2014) , proteaseactivated receptor1 (Soto et al., 2015) , M 1 (Keov et al., 2014) and M 2 (Gregory et al., 2010) muscarinic receptors) and contributes to constitutive activity [H 4 histamine (Wifling et al., 2015) , complement factor 5a (Klco et al., 2005) and MC 1 /MC 2 melanocortin receptors (Holst and Schwartz, 2003) ].
Here, we have investigated, specifically, the role of the E2 loop in MT 1 receptors and GPR50, by exploring the functional behaviour of MT 1 -GPR50 chimeric receptors in terms of ligand binding and signal transduction, assisted by computational structural receptor models.
Methods

Cell culture and transfection
Human embryonic kidney 293T (HEK293) cells were cultured in DMEM medium supplemented with 10% fetal bovine serum and penicillin/streptomycin. Cells were transfected with polyethylenimine (PEI) (Polysciences Inc.; Niles, IL, USA), Xtremegene 9 (Roche Diagnostics, Basel, Switzerland) or by electroporation (GenePulserXcell, Bio Rad; Hercules, CA, USA) according to the supplier's instructions.
DNA constructs
The pcDNA3-CMV vectors expressing the human wild type MT 1 receptor and GPR50 were described previously (Levoye et al., 2006; Maurice et al., 2010) . All MT 1 and GPR50 chimera have been generated by chemical synthesis and verified by sequencing. The different domains were defined as follows: N-terminal of GPR50 (Met1-Pro25), C-terminal of MT 1 receptors (Ser312-Val350), TM6 of MT 1 (Asp233 6.30 -Ala262 6.59 ) and GPR50 (Glu232 6.30 -Ala261 6.59 ),
E2b(C + 7) ) and GPR50 (Thr175 E2b(C-3) -
Asn185
E2b(C + 7) ). Domains corresponding to the E2 loop of M 2 (Gly167 E2a(C-9) -Ala184
E2b(C + 8) ) and M 3 (Val210 E2a(C-10) -Glu227 E2b(C + 7) ) muscarinic acetylcholine receptors have also been synthesized, as they show size and hydrophobicity properties, similar to those of the E2 loop of MT 1 .
Radioligand binding experiments
Membranes from HEK293T cells transiently expressing the different receptor constructs were prepared as previously described (Ayoub et al., 2004) . 2-[ 125 I]iodomelatonin saturation binding experiments were performed in the range of 1-1000 pM, and specific binding was defined as binding displaced by 10 μM iodomelatonin. Assays were carried out in duplicates for 120 min at 37°C, followed by rapid filtration through GF/F glass fibre filters (Whatman; Clifton, NJ, USA). Filter-retained radioactivity was determined with a γ-counter (LB2111; Berthold Technologies, Bad Wildbad, Germany).
Homogeneous time-resolved fluorescence (HTRF)-based cAMP assay cAMP levels were determined in HEK293 cells transiently expressing wild-type MT 1 , GPR50 or chimeric receptors by HTRF using the 'cAMP femto2' kit (Cisbio, Bagnols-sur-Cèze, France) according to the manufacturer's instructions. Cells were incubated with 2 μM forskolin and different concentrations of melatonin at room temperature for 30 min. Data were fitted by non-linear regression to determine E max and EC 50 values and normalized to the forskolin-induced response (as 100%) and melatonin-induced maximum inhibition (as 0%) using GraphPad Prism software.
BRET-based β-arrestin2 recruitment assay
For the ß-arrestin2 recruitment assays, cells were transfected with plasmids coding for different receptors and the Rluc8-ß-arrestin2-YPet biosensor. Forty-eight hours posttransfection cells were washed once with PBS, and Coelenterazine h substrate was added at a final concentration of 5 μM and left for 10 min at room temperature. Cells were then stimulated by different concentrations of melatonin for 5 min (Kamal et al., 2009) . BRET readings were made, using a lumino/fluorometer (Mithras; Berthold Technologies, France) allowing sequential integration of luminescence with three filter settings (Rluc filter, 485 ± 10 nm; YFP (and YPet) filter, 530 ± 12.5 nm, RGFP filter, 515 ± 10 nm). Emission signals at 530 or 515 nm were divided by emission signals at 485 nm. The difference between this emission ratio obtained with donor and acceptor fused or co-expressed and that obtained with the donor protein expressed alone was defined as the BRET ratio. Data were fitted by non-linear regression to determine E max and EC 50 values using GraphPad Prism software.
SDS-PAGE/Western blot
Homology modelling of MT1, mutMT1 receptors and GPR50
The sequences of MT 1 , hGPR50, bovine rhodopsin, turkey β 1 -adrenoceptor, hβ 2 -adrenoceptor and hA 2A receptors corresponding to P48039, Q13585, P02699, P07700, P07550 and P29274 Uniprot IDs, respectively, were aligned using ClustalΩ (Sievers et al., 2011) . Only sequences corresponding to crystal structures of bovine rhodopsin (1U19 pdb entry) (Okada et al., 2004) , turkey β 1 -adrenoceptor (2VT4) (Warne et al., 2008) , hβ 2 -adrenoceptor (2RH1) (Cherezov et al., 2007) and A 2A receptor (A2AAR) (3EML) (Jaakola et al., 2008) were aligned. Based on the size of E2, I3 and E3 variable regions, rhodopsin was the closest template. That is why we used a full-sequence alignment with rhodopsin, adrenoceptors and adenosine receptors only in conserved regions (I1, I2, E1 and TM domains), whereas the coordinates of variable E2, I3 and E3 regions were inherited only from the rhodopsin template. This initial alignment was manually refined using Chimera (Pettersen et al., 2004) to adjust some of the gaps in the E2, I3 and E3 loop regions and align conserved cysteine residues (Cys100 3.25 , Cys177
of MT 1 , Cys178 of GPR50) (Supporting Information Figure  S1 ). Apo-receptor structures for MT 1 , mutMT 1 (chimeric receptor containing the last 11 C-terminal amino acids) (Ile174 E2b(C-3) -Ser184 E2b(C + 7) ) of the E2 of the MT 1 receptor replaced by the corresponding region of GPR50 (MT 1 [E2b-GPR50]) and GPR50 systems were modelled with Modeller program (Webb and Sali, 2014) . Disulfide bridges were added between Cys3.25 (Cys100 MT1R and Cys101 GPR50 ) and central cysteine residue of E2 (Cys177 MT1R and Cys178 GPR50 ). All models were subjected to thorough molecular dynamics (MD) optimization. The five best-scoring models were inspected visually, mapped to Ramachandran diagrams and the most suitable model of each complex was selected in terms of low score and structure of the loops. Melatoninbound states of MT 1 , mutMT 1 receptors and GPR50 resulted from the best docking pose of melatonin, by GoldScore scoring function, into a sphere described by a radius of 14 Å around the centroid of the only solvent accessible surface under the extracellular region, using GOLD suite v5.2 (Jones et al., 1995) within the Hermes v1.6 GUI (CCDC©). The goal was to get suitable complex as inputs for molecular dynamics which was the core method to reach very low energy states of each holo-receptor.
MD simulations
Protein models were embedded into a triclinic lipid bilayer composed of 368 dipalmitoylphosphatidylcholine (DPPC) molecules and was hydrated into a layer of approximately 30 Å on each side. After addition of chloride ions to achieve charge neutrality, the final system contains a total of roughly 77 000 atoms. In a second step, the inflateGRO method (Kandt et al., 2007) was used to optimize the packing of lipids around the protein. This protocol aims to inflate and then iteratively increase, the density of lipids up to an optimal value of area per lipid observed on to an equilibrated DPPC membrane (Nagle, 1993) . The system was then equilibrated restraining the α-carbon trace in the NVT (constant N particles, volume and temperature ensemble) then NPT (constant N particles, pressure and temperature ensemble) ensemble before unrestrained MD simulations (3 × 300 ns) in the NPT ensemble, using Langevin dynamics to control temperature at 323 K, and at a time step of 2 fs, while constraining all bonds between hydrogen and heavy atoms. MD simulations were carried out with GROMACS 5.0 (Pronk et al., 2013) using the c36 CHARMM forcefield (Best et al., 2012) . The GROMACS topology of melatonin was generated from PRODRG webserver (Schüttelkopf and van Aalten, 2004 
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 (Alexander et al., 2015) .
Results
Essential role of E2 loop for MT 1 receptor function
To study the role of the E2 loop in MT 1 receptor function, we generated a series of chimeric receptors between the melatonin binding-competent MT 1 receptor and the melatonin binding incompetent GPR50 and studied their functional properties in HEK293 cells (see Figure 1A for the sequence alignment of E2 loops for GPCRs referred to in this study). Both wild-type receptors showed the expected properties, MT 1 receptors bound 2-[ 125 I]MLT with high affinity (K d 233 ± 20 pM), activated the G i /cAMP pathway and recruited ß-arrestin2, and GPR50 was completely inactive in all assays ( Figure 1B ; Table 1 ). The chimeric receptor containing the predicted E2 loop (residues 164-185) of the MT 1 receptor replaced by the entire corresponding region of GPR50 (MT 1 [E2-GPR50]) or only the C-terminal 11 amino acids (MT 1 [E2b-GPR50], see below) was inactive in all three assays ( Figure 1B ; Table 1 ). Replacement of the N-terminal domain of the MT 1 receptor by its GPR50 counterpart (MT 1 [Nter-GPR50]) had only a modest effect on its function (Table 1 ; Supporting Information Figure S2A ) supporting the specificity of the effect observed with the two E2 loop chimeras. Figure 1C , D). Homology modelling of the human MT 1 receptor in its inactive form indicated a tight hairpin structure of the MT 1 E2 loop and a separation into two distinct parts of the hairpin, an N-terminal E2a part composed of 10 amino acids (Arg164 E2a(C-13) -Arg173 E2a(C-4) ) and a C-terminal E2b part composed of 11 amino acids (Ile174 E2b(C-3) -Ser184 E2b(C + 7) ) labelled relative to the reference Cys177 position (Figure 2 ). Based on the Fredriksson's phylogenetic tree (Fredriksson et al., 2003) , rhodopsin, β 1 -adrenoceptor, β 2 -adrenoceptor and A 2A adenosine receptor crystal structure templates turned out to be the closest homologous templates of the three MT 1 , mutMT 1 (MT 1 [E2b-GPR50]) and GPR50 sequences, particularly within the α-class of rhodopsin-like family (Supporting Information Figure S1 ). For the modelling of the E2 loop, rhodopsin represented the most suitable template. In contrast to the α-helical organization of the E2b part in β-adrenoceptors or the additional 3-residues deletion in the E2a part of the A 2A receptor, the extended conformation of rhodopsin E2b
facilitates the location of the 5-residue deletion in the coil of the hairpin keeping the spatial constraint of the conserved Cys177 for disulfide bridge formation with Cys100 3.26 without any impairing constraint for TM4-E2 and E2-TM5 junctions (Supporting Information Figure S1 ). In addition to this shortened length of E2b, the spatial constraint due to the predicted disulfide bridge between Cys177 in E2b and Cys100 3.26 contributes to a tight hairpin structure of the MT 1 E2 loop. A similar structural organization of the E2 loop into two structurally distinct elements has been previously proposed for other GPCRs (Nygaard et al., 2009) . The three selected MT 1 , mutMT 1 and GPR50 homology models were very close to each other with a RMSD lower than 1 Å from the α-carbon pairwise alignment of 283 homologous amino acids (Supporting Information Figure S1 ). Nevertheless, at this level, before MD simulations, we observed a first slight difference in the folding of E2b between MT 1 , mutMT 1 and GPR50 apo-models. Replacement of the E2b element of the MT 1 receptor by its GPR50 counterpart (MT 1 [E2b-GPR50]) abolished receptor function, thus experimentally validating the importance of the E2b element (Table 1, Figure 1B ). Inspection of the sequence of the E2b element revealed five residues that are homologous between MT 1 and MT 2 receptors but differ in the GPR50 sequence (Ile/Thr E2b(C-3) , Thr/Ile E2b(C + 1) ,
Gln/Tyr E2b(C + 4) , Ser/Asn E2b(C + 7) and Ser/Asn E2b(C + 7) ) ( Figure 1A ). Replacement of Ile174 E2b(C-3) and Thr178
by their GPR50 counterparts (MT 1 [I174T, T178I]) did not impair MT 1 receptor function, whereas replacement of Gln181 E2b(C + 4) , Ser182 E2b(C + 5) and Ser184
E2b(C + 7)
(MT 1 [Q181Y, S182L, S184N]) severely diminished its function ( Figure 1E , Table 2 , Supporting Information Figure  S2D ). Similar results were obtained with single or double mutants (MT 1 [Q181Y], MT 1 [S182L,S184N], MT 1 [S184N]) of these residues ( Figure 1E , Table 2 and Supporting Information Figure S2D ). To further evaluate the effects of Gln181 E2b(C + 4) , Ser182 E2b(C + 5) and Ser184 E2b(C + 7) residues on MT 1 receptor function, we placed them back in the MT 1 [E2b-GPR50] chimera and monitored for restoration of function in this loss-of-function background (MT 1 [E2b-GPR50]Y181Q, L183S,N185S, N185S). Interestingly, responses to melatonin were restored in Y181Q and L183S, N185S mutants ( Figure 1E , Table 2 and Supporting Information Figure S2D ). Collectively, our results show the importance of the E2b element of the MT 1 receptor and particularly the C-terminal region of the E2b element close to TM5 for 2-[ 125 I]MLT binding and MT 1 receptor activation.
Exchange of the E2 loop of GPR50 for its MT 1 counterpart is sufficient to promote melatonin-induced activation of GPR50
To better understand the role of the E2 loop in MT 1 receptor function, we introduced the latter into GPR50 (GPR50[E2-MT 1 ]) in an attempt to induce sensitivity to melatonin in GPR50. This chimera was indeed fully functional in terms of coupling to the G i /cAMP pathway and β-arrestin2 recruitment ( Figure 1B , Table 1 and Supporting Information Figure  S2D ). High-affinity 2-[ 125 I]MLT binding was not measurable, porbably due to the lower sensitivity of the binding assay as compared to the functional assays, which are based on signal amplification. Replacement of the E2 loop of GPR50 by the E2 Figure 1 Pharmacological investigations of wild-type and chimeric MT 1 /GPR50 receptors. (A) Sequence alignment of E2 loops of GPCRs referred to in this study. Sequence identity appears in shades of blue. (B) Melatonin-induced activation of the G i /cAMP pathway and recruitment of ß-arrestin2 (see also Table 1 and Supporting Information Figure S2D ). (C) Representative Western blot detection of receptor expression levels in cell lysates. (D) Quantification of receptor expression. Data are expressed as mean ± SEM of at least five independent experiments (n is shown in the bars for each group). (E) Melatonin-induced activation of the G i /cAMP pathway in mutated MT 1 and MT 1 /GPR50 chimera (see also Table 2 and Supporting Information Figure S2E ). Table 1 In vitro activity of chimeric MT 1 /GPR50 mutants Table 1 and Supporting Information Figure S2C , D). This confirms that the specific and positive effect of the E2 loop of the MT 1 receptor can be transferred to GPR50 and excludes a possible inhibitory effect of the E2 loop of GPR50 on GPR50 function.
Putative role of the E2 loop into the orthosteric binding site of melatonin 3D homology models of free and melatonin-bound MT 1 , mutMT 1 (MT 1 -[E2b-GPR50]) receptors and GPR50 were built, refined and analysed in order to identify differential molecular features of the E2 loops that could explain such contrasting pharmacological profiles. The first hypothesis to be investigated was the potential participation of the E2 loop in the direct binding of melatonin. These investigations have been based on the putative orthosteric binding sites that are supposed to be the most voluminous solvent accessible cavity close to the extracellular region. All three receptor models revealed the presence of a comparable cavity. Three prototypical holoreceptor models (MT 1 , mutMT 1 and GPR50) were built resulting from the top-scored docking pose of the most populated binding mode. Specific interactions between receptors and melatonin were then studied after triplicated 300 ns MD simulations of energy relaxation. Only one of the nine simulations, concerning the mutMT 1 receptor system, was not taken into account as it showed the migration of melatonin into the lipid bilayer. Monitoring the displacement of melatonin during MD simulations showed its rapid stabilization in holo-MT 1 and holo-mutMT 1 . On the contrary, although the fluctuations of melatonin appear to be flat by the end of the simulations because of the holo-mutMT1R0 artefact, a significant instability of melatonin still remained until 300 ns in holo-GPR50 (Supporting Information Figure  S3 ). This finding would argue for more stable MT 1 -melatonin and mutMT 1 -melatonin, than GPR50-melatonin, complexes. From a thermodynamic point of view, we aimed at linking the binding affinity of melatonin in all holo-receptors to the frequency of detected intermolecular interactions during MD simulations. Although there are as many residues involved in both hydrogen bonding and hydrophobic interactions in both MT 1 and GPR50 receptors, interactions are significantly more frequent in MT 1 receptors than in GPR50 (Figure 2A ). Melatonin fits between TM 3, 4, 5 and 6 under the E2 loop. Consistent with the aromatic nature of the indole core of melatonin, most of the interactions detected were hydrophobic. The three most frequent intermolecular interactions observed between melatonin and the MT 1 receptor involved residues Val111 3.36 (35%), Tyr170 E2a(C-7) (33%) and Phe196 5.47 (30%) ( Figure 2B ), whereas the relative frequencies of these amino acids in mutMT 1 and GPR50 were lower than 22% and 17% respectively. To a lesser extent, Tyr187 5.39 and Phe256 6.53 complete the hydrophobic binding pocket, whereas Asn255 6.52 makes the only significant polar interaction with the amide extremity of melatonin in the MT 1 receptor, but not in mutMT 1 or GPR50 ( Figure 2B ). His195 5.461 has already been identified as part of the melatonin binding pocket of MT 1 (Kokkola et al., 2003) and MT 2 receptors (Conway et al., 1997) and, more generally, to be important for ligand stabilization or receptor activation of GPCRs (Almaula et al., 1996) . Collectively, 3D homology
Figure 2
Essential residues for the binding of melatonin from MD simulations. (A) The distributions show the percentage of the 3000 frames, covering 300 ns MD simulations that form hydrogen bonds or hydrophobic contacts between melatonin and each residue detected at least once in contact, using MT 1 , mutMT 1 or GPR50 receptors. The frequency of each intermolecular receptor-melatonin interaction was deduced from triplicates for MT 1 -MLT and GPR50-MLT and from duplicates for mutMT 1 -MLT (please see Figure S3 for more details). For comparison, residues are identified with Ballesteros numbering with the exception for E2 residues, identified by their relative position to the conserved cysteine residue. (B) The most representative illustration of intermolecular interactions with melatonin (MLT) in MT 1 (blue), mutMT 1 (green) and GPR50 (red) holo-receptor models are represented from a frame chosen at a time displaying most of highlighted residues in some lateral and extracellular views on the left and the right panels respectively. E2a and E2b segments of E2 loop are illustrated as yellow and red tubes respectively.
modelling suggested that the E2 loop forms an extracellular cap over the melatonin binding pocket within the TM bundle but is unlikely to participate directly in melatonin binding to MT 1 receptors.
Flexibility and folding of the E2 loop in MT 1 , mutMT 1 and GPR50 models
Based on the weak fluctuation of the E2 loop observed during MD simulations, we anticipate that this region undergoes a conformational restriction as a hairpin tensor, a feature that might be different between the three receptor models (Figure 3) . In contrast to the impaired mutMT 1 and GPR50 models, most of the E2b residues in the MT 1 model are folded in regular units which are conserved during MD simulation of apo/holo-MT 1 models (Supporting Information Document S4). In comparison with apo-GPR50 simulation, there are significantly less regular folded units in holo-GPR50. Binding of melatonin in holo-GPR50 seems thus to alter the E2 structure rather than stabilize it, as in the holo-MT 1 simulation. All these findings argue in favour of a specific folding of the E2 loop which is stabilized in functional MT 1 receptors, but not in impaired apo-mutMT 1 or GPR50 systems. Nevertheless, although the E2b elements are structurally rigid during simulations of mutMT 1 and GPR50 systems, the global folding of their E2 loop seems clearly different. The E2a element of apo-GPR50 tolerates an additional flexibility, due to the unstable flanking TM4, which thus shifts major folding units as 'bend' features towards this N-terminal region of E2. On the other hand, apo-mutMT 1 exhibits a rigid E2a element due to a higher stability of the flanking TM4, whereas the exchange of the MT 1 E2b for its GPR50 counterpart induces a significant flexibility. This could be considered as an anomalous local instability, probably due to an addition of 20 atoms within this packed folding of the E2b element, which induce a spatial restraint forcing a singular 'bend' folding unit from 220 ns until the end of the apo-mutMT 1 MD simulation. All together, these data show that the E2 loop exhibits a common hairpin folding, however with important individual differences for each receptor model studied. This loop is rigid and stable in MT 1 receptors and GPR50 but much more regularly folded in MT 1 receptors, whereas the E2b element is unstable in mutMT 1 receptors. Although the E2 loop seems to be positioned on top of the melatonin binding pocket, it does not seem to be flexible enough to act as a dynamic gate to regulate melatonin accessibility to the binding pocket, by itself.
Interaction of the E2 loop with TM domains in MT 1 , mutMT 1 and GPR50 models
We then evaluated whether differential interactions of the E2 loop with the TM domain or other extracellular regions (ERs) could explain the difference between active (MT 1 ) and inactive (mutMT 1 and GPR50) receptor models (Figure 4 ). Most intramolecular interactions of the E2 loop detected during MD simulations were apolar contacts. The E2 loop of the functionally inactive apo-mutMT 1 and apo-GPR50 preferentially interacts with ER ( Figure 4A ), whereas the E2 loop of the functionally active apo-and holo-MT 1 preferentially interacts with the TM domain ( Figure 4B ). These hydrogen bonds exist particularly between Gln181 E2b(C + 4) ( Figure 4D) and Thr188 5.40 , observed in 40% of all conformations sampled from holo-MT 1 MD simulations ( Figure 5A ). Experimental data showed that mutation of Gln181 into its GPR50 Tyr counterpart (MT 1 [Q181Y]) had only a minimal effect on melatonin binding and receptor signalling ( Figure 1E , Table 2 and Supporting Information Figure S2E ). Conversely, introduction of a single Tyr181 residue in the functionally inactive MT 1 [E2b-GPR50] chimera was able to restore function to the MT 1 [E2b-GPR50]-Y182Q chimera ( Figure 1E , Table 2 and Supporting Information Figure S2E ) supporting its important role in MT 1 receptor function. During MD simulation of the MT 1 model, we also detected significant interactions between TM6 and the E2 loop. In terms of polar interactions, one hydrogen bond was found between Tyr170 E2a(C-7) and Asn255 6.52 in 25% of the sampled conformations. Although not observed simultaneously, Asn255 6.52 may also interact with melatonin (see above). Four additional apolar contacts were observed between Phe179 E2b(C + 2) ( Figure 4D ) and (Conway et al., 2000; Gubitz and Reppert, 2000) . Another favourable aromatic contact was frequently identified between Phe179 E2b(C + 2) and Tyr281 7.39 (residue conserved in GPR50) in the holo-MT 1 model. 
The effect of melatonin on cAMP pathway is expressed as pEC 50 ± SEM (M), while the maximal effect is expressed as a percentage of the maximal effect induced by forskolin (Fsk). Data are mean of at least four independent experiments; each of them performed using at least eight different ligand concentrations. *P < 0.05, significantly different from MT 1 ; two-tailed Student's t-test.
In the two inactive models (mutMT 1 and GPR50) the E2 loop showed more interactions with the ER (Figures 4C and 5B, C), in particular van der Waals or aromatic interactions are observed between the E2b part (Tyr175/176 C-2 , Ile178/179 C + 1 , Phe179/180 C + 2 and Tyr181/182 C + 4 ) and the N-terminal region (Met1, Gly5, Leu8, Leu16, Arg17 and Arg22 in the apo-mutMT 1 model and Met1, Gly2, Pro3, Val7, Pro8, Pro10, Tyr11, Gly12, Ile14, Gly15, Leu18, Pro19 and Tyr23 in the apo-GPR50). The same type of interactions was also observed between the E3 loop (Pro264 and Lys265 of GPR50; Pro265 of mutMT 1 ) and Phe179/180 E2b(C + 2) or Tyr181/182 E2b(C + 4) . Consequently, although Phe179
is conserved between MT 1 and GPR50 receptors, its interactions are different. Its central position in the E2 loop makes the orientation of its side chain dependent on the E2b sequence and folding. As a result, our data converge towards a differential network of interactions established by E2b loop positions C + 2 and C + 4 in functional, as distinct from impaired, systems. In the inactive mutMT 1 and GPR50 systems, Phe179/180 E2b(C + 2) and Tyr181/182 E2b(C + 4) of E2b are predicted to favour a large amount of hydrophobic interactions with the N-terminus and E3 loop of the ER, whereas the analogous residues in the functional holo-MT 1 system (Phe179 E2b(C + 2) and Gln181 E2b(C + 4) ) are engaged in more buried interactions with TM5, TM6 and TM7 ( Figure 5 ).
In vitro evidence for an E2b-TM6 unit supporting MT 1 receptor activity Molecular modelling indicated preferential interaction of the E2b element with TM5, TM6 and TM7 in the melatoninbound holo-MT 1 model ( Figure 5A ). Replacement of TM5 and TM7 by its GPR50 counterpart (MT 1 [TM5-GPR50] and MT 1 [TM7-GPR50]) is known not to affect MT 1 receptor function (Conway et al., 2000; Gubitz and Reppert, 2000) . This observation is compatible with our holo-MT 1 model as Thr188 5.40 and Tyr281 7.39 , the residues interacting respectively with Gln181 E2b(C + 4) and Phe179 E2b(C + 2) of the E2b Figure 3 Structural folding of the E2 loop in MT 1 , mutMT 1 and GPR50 receptors. 3D folding was appreciated during MD simulations in term of root mean square fluctuation expressed by scaled B-factor in nm 2 (A) and by the assignment of secondary structures (B) by the DSSP method (Kabsch and Sander, 1983) focusing onto the studied E2 loop and its flanking regions (140-220). A detailed analysis of the E2 loop folding is available in Supporting Information Document S4.
Figure 4
Numbers of intramolecular interactions involving the E2 loop. The most conserved interactions were identified if their frequency was greater than 50% for apolar contacts or 20% for hydrogen bonds during MD simulations. The illustration focuses on nature of apolar or polar interactions from E2a or E2b moieties with ER (A) or TM (B). In (C) and (D), the individual residues of the E2 loop in each receptor model participating in the interactions with ER are shown in (C) or with TM in (D).
element, are conserved between MT 1 receptors and GPR50. In contrast, a similar exchange of TM6 (MT 1 [TM6-GPR50]) generated an inactive receptor indicating its functional importance (Conway et al., 2000; Gubitz and Reppert, 2000) . To verify the relevance of TM6 more directly, we transferred TM6 of the MT 1 receptor into the GPR50 backbone (GPR50[TM6-MT 1 ]) to see whether we could make GPR50 responsive to melatonin, which was indeed the case for the G i / cAMP pathway activation and ß-arrestin 2 recruitment (Table 1 and Supporting Information Figure S2A , D Figure S2A , D). Based on our molecular modelling results, Gln181
E2b (C + 4) and Phe179 E2b(C + 2) in the E2 loop seemed interesting candidates to interact in the MT 1 receptor with TM5 (Thr188  5.40 ) and TM6 (Ile257 6.54 ) respectively. The absence of these interactions in models of the inactive MT 1 [E2b-GPR50] chimera is in agreement with this hypothesis. To further validate these predictions experimentally, we performed functional assays with MT 1 receptors carrying mutations in TM6. Gly258 6.55 has been previously identified to be important for MT 1 receptor function, in particular in combination with Ala252 (Table 3 and Supporting Information Figure S2B ). Loss of signalling function in the Q181Y/G258T double mutant confirmed the importance of G258 for MT 1 receptor function. The substitution I257L alone (MT 1 [I257L]) showed 2.5 times lower affinity for 2-[ 125 I]MLT binding and no signalling capacity (Table 3 , Supporting Information Figure S2B ). To further study the relationship of Gln181 E2b(C + 4) with Ile257 (Table 3 and Supporting Information Figure S2B ).
Discussion
The MT 1 receptor and GPR50 constitute an interesting case as both receptors show high sequence homology yet are functionally very different, as MT 1 receptors bind melatonin with high affinity and GPR50 receptors appear to have lost this capacity in mammals. Here, we present evidence that differences in the primary and secondary structure of the E2 loop
Figure 5
Clusters of intramolecular interactions involving the E2 loop. (A) holo-MT 1 , (B) apo-mutMT 1 and (C) apo-GPR50. Cylinders represent TM domains, whereas loops are represented by ribbons. Peptidic backbones of E2a and E2b are illustrated in yellow and red respectively. In each illustration, domains interacting with the E2 loop appear as opaque, whereas the remaining structure is transparent.
explains the ability of MT 1 receptors to bind melatonin and the inability of GPR50 to do so. According to MD simulations, the E2 loop of MT 1 receptors and GPR50 receptors tends to fold as a hairpin composed by two distinct strands that we identified as E2a and E2b, respectively, flanking TM4 and TM5. Nevertheless, there is a major difference in the structure of the E2 loop of MT 1 and GPR50 receptors. In contrast to GPR50, the E2 loop of MT 1 receptors exhibits more regular folding units like a β-hairpin (antiparallel β-sheet) or B-bridge-hairpin (a unique hydrogen bond). These hairpin structures form an extracellular cap over the melatonin binding pocket, which is located within the TM bundle. Intriguingly, GPR50 exhibits a putative ligand binding cavity similar to MT 1 receptors in terms of volume and location. Consequently, even though the interactions between GPR50 and melatonin are more scattered in this virtual model and occur with a lower frequency than in the holo-MT 1 model, particularly because of an irregular folding of the TM4 region flanking the E2a element of the E2 loop, it is not enough to explain the total loss of melatonin binding. Besides, we also observed that the E2 loop did not participate significantly in the orthosteric binding of melatonin with only one residue of E2a, Tyr170
E2a(C-7) , stacking its indole scaffold by aromatic contacts, but which is identical in GPR50. Although exchange of the E2b region between MT 1 and GPR50 receptors makes this region unstable during MD simulations, the chimeric mutMT 1 receptor also contains an appropriate binding site to fit melatonin. For all these reasons, we suspect that ligand accessibility controlled by the E2 loop is the major differential event promoting melatonin binding to MT 1 receptors and preventing access to the orthosteric binding pocket of GPR50. According to our model, the E2 loop of MT 1 receptors caps the melatonin binding pocket and thus decreases its accessibility ( Figure 6 ). The known crystal structures of class-A GPCRs with similar closed capping of the binding site by the extracellular region containing a β-hairpin E2 loop are rhodopsin (Palczewski et al., 2000) and the S1P 1 receptor (Hanson et al., 2012) . The hydrophobic nature of their ligands was suggested to force these ligands to access their binding site by diffusing through the membrane (Hurst et al., 2010) . Biophysical studies have shown that melatonin distributes rapidly in the aqueous and lipid phase indicating that melatonin could approach the receptor from both phases (Shida et al., 1994; Costa et al., 1997; Yu et al., 2016) . Performing several exploratory computational experiments of restrained MD simulations steering the melatonin off the binding site, we highlighted a putative accessibility pathway between extracellular extremities of TM5 and TM6 (Supporting Information Electronic Material S5). Interestingly, the E2b element is involved in this pathway by interactions between the amide group of melatonin and Gln181 E2b(C + 4) found to be essential in silico to form E2-TM5 units in the holo-MT 1 model but also experimentally in vitro to restore function to a chimeric mutMT 1 receptor, if Tyr181 is replaced by Gln (MT 1 [E2b-GPR50]-Y182Q) ( Figure 1E , Table 2 and Supporting Information Figure S2E ). However, this computational method is so biased by high force constants that such a ligand accessibility pathway could also be found in GPR50, even though it would be theoretically impossible at a thermodynamic level. It only suggests that, combined with the demonstrated weak flexibility of the E2 loop, some structural features of the E2b element in GPR50 and the related chimeric mutMT 1 would be enough is conserved between MT 1 receptors and GPR50, its orientation is modified by more steric surrounding variable side chains and provokes an extracellular hydrophobic cluster with N-terminal and E3 regions in the GPR50 model. Interestingly, Phe179 E2b(C + 2) and Gln181 E2b(C + 4) are conserved in Mel1c, the orthologue of GPR50 in lower vertebrates that binds melatonin with high affinity ( Figure 1A) . Consequently, the E2 loop is likely to play a role in the conformational changes associated with MT 1 receptor activation, rather than in melatonin binding. Similar to rhodopsin (Ahuja et al., 2009) , participation of the E2 loop of MT 1 receptors and, particularly the E2b element, in the stabilization of TM 5, 6 and 7 of the active melatonin-bound form of the receptor could favour the conformational changes necessary for signal transmission to the cytoplasmic receptor surface. In the case of GPR50, the steric hindrance of E2b tends to favour interactions with other extracellular region, accentuating the volume of the extracellular cap and occluding the putative access pathway to the ligand binding pocket between extracellular extremities of TM5 and TM6.
The possible clinical relevance of this study resides in the identification of the E2 loop as the first site of interest for allosteric modulation of MT 1 receptor activity. Compounds targeting the E2 loop of MT 1 receptors are expected to behave as allosteric modulators. Currently, no allosteric modulators have been identified for these receptors. Such compounds are of particular interest as they would not alter the natural circadian activation pattern of melatonin receptor activity which is essential for a chronobiotic hormone, such as melatonin.
In conclusion, in silico molecular modelling and MD simulations and in vitro functional studies indicate that the E2 loop of MT 1 receptors is critical for its function by regulating access to the melatonin binding pocket and/or favouring the conformational changes necessary for signal transmission across the membrane to the cytoplasmic receptor surface. In contrast, the E2 loop of GPR50 is unable to fulfil this function(s) providing a first explanation why GPR50 does not bind melatonin despite the presence of a comparable ligand binding pocket.
Figure 6
Surface of the MT 1 receptor from the extracellular (A) and lateral (B) view. E2a and E2b appear as yellow and red surfaces respectively, whereas the remaining receptor surface is in cyan. Melatonin is illustrated as a green space-filling model. 
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https://doi.org/10.1111/bph.14029 Figure S1 Sequence homology of melatonin receptors. According to GRAFS phylogenetic tree (Fredriksson et al., 2003, Mol Pharmaco) , the closest sequences of crystal templates from melatonin MT 1 (MTNR1A) and MT 2 (MTNR1B) receptors and GPR50 are rhodopsin (RHO), β-adrenoceptors (ADRB1 and ADRB2) and A2A (ADORA2A) adenosine receptors (A). Sequence identity and homology rates were computed for the whole or transmembrane region (B) whereas the multiple sequence alignment used by Modeller for homology modelling of MT1 receptor was manually adjusted after an automatic alignment (clustalΩ) in order to shift gaps outward the helical transmembrane regions (C). Panel D shows a superimposition of selected apo-models of MT1, mutMT1 and GPR50 models. Figure S2 Signalling and expression of wild type and chimeric MT 1 /GPR50 receptors. (A) Melatonin-induced activation of the G i /cAMP pathway and recruitment of ß-arrestin2 of receptors summarized in Table 1 . (B,C) Melatonin-induced activation of the G i /cAMP pathway of receptors summarized in Table 3 . (D-F) Representative Western blot detection of receptor expression levels in cell lysates (D, E, F chimera from Tables 1, 2, 3, respectively). Western blots are representative of at least 3 independent experiments. Figure S3 Structural deviation of melatonin during MD simulation of holoMT1, holoMT1mut and holoGPR50 receptors. The structural deviation (nm) is computed in term of RMSD to the reference t0 frame of both 300 ns MD simulations after fitting the α-carbon trace in each of three replicated experiments. Document S4 Detailed analysis of E2 folding in MT1, mutMT1 and GPR50 receptor models during MD simulations. Electronic Material S5 Motion of a possible ligand accessibility pathway from supervised MD simulation steering the melatonin off the binding site of MT 1 .
